Colombia vs Congo: The number of people with susceptibility test result for rifampicin
Colombia
39.17
in 2021
Congo
42.71
in 2021
Colombia rank
125th
Congo rank
122nd
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Congo
How they compare
Congo currently reports 42.71 against 39.17 in Colombia, a difference of 3.54.
That makes Congo's figure about 1.1 times Colombia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Colombia ahead.
Colombia ranks 125th and Congo ranks 122nd of 146 countries.
Across the 2 decades both report, Colombia averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Colombia | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.03 | 15.4 | 6.64 | Colombia |
| 2020s | 29.98 | 71.35 | 41.37 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Congo?
- Congo, at 42.71 against 39.17 in Colombia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Congo?
- 3.54, with Congo ahead.
- How many years of comparable data are there for Colombia and Congo?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Congo rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 125th and Congo ranks 122nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.